Growth Stock Wire Investment Newsletter

 
Growth Stock Wire Investment Newsletter About Growth Stock Wire Frequently Asked Questions Growth Stock Wire Archives Contact Us Privacy Policy
Print Edition | Sponsored Link:

Steady Double Digits in One of the Last Bull Markets
By Ian Davis
September 22, 2008

In the last six months, only 19 of the 100 sectors I track have reached a new high.

And almost all of the 19 are related to commodities. They include miners, producers, explorers, and transporters of minerals and energy.

But there are a couple of exceptions...

With the recent buyout of Budweiser by InBev, brewers reached new highs about seven weeks ago. Another out- performer I've written about before is the Biotech sector. It's making new highs despite the slowdown in the economy.
 
The most recent sector to climb to new highs is related: medical equipment makers.

Medical equipment makers are close cousins to the biotech sector. Both research and develop products for the health care industry. But this sector is not as cyclical as biotech.

It's up 5.6% in the last six months. The S&P is down 9.3% over the same time.

Medical Equipment Companies Fall Only in Times of
Extreme Panic
The Two-Year Trend Is Up in Natural Gas

As you can see, two severe selloffs have occurred in the last 18 years.

The first happened at the tail end of the dot-com bust in mid-2002. This decline roughly matched the S&P 500's performance at the time (medical equipment makers declined 31%, the S&P 28%). It was a simple case of universal panic.

The other began at the end of 2005. A cardiac defibrillator paddle malfunction caused the death of a 21-year-old. As you can imagine, investors were spooked. The entire sector sold off by about 18%.

Besides these two instances, the sector's returned a consistent 11% per year.

However, medical equipment makers are slightly expensive right now. They have a price-to-earnings ratio of 27.6, 23% above their long-term median of 22.4, and a price-to-book ratio of 3.36, 7% above their long-term median of 3.1.

The Medical Equipment Sector Is Slightly Expensive
The Two-Year Trend Is Up in Natural Gas

So are medical equipment makers a good buy?

The One Place to Make a Fortune in the Market Right Now

When Drug Makers Aren't Selling Drugs...

I'd wait for a selloff before buying. The sector is not immune to investor panic. And I think we could easily run into another bout of panic before this bear market is over.

However, as a long-term hold, medical equipment makers are hard to beat. The sector has shown a fairly consistent 10% annualized return since the 1970s.

Good investing,

Ian Davis

Markets Soar on Government Intervention
The federal government is working on a sweeping series of programs that would represent perhaps the biggest intervention in financial markets since the 1930s, embracing the need for a comprehensive approach to the financial crisis after a series of ad hoc rescues.

Treasury Secretary Henry Paulson announced plans Friday to quickly set up a "bold" government program to take over troubled mortgage assets from financial institutions, along with other efforts to step up the purchase of mortgage-backed securities. "The federal government must implement a program to remove these illiquid assets that are weighing down our financial institutions and threatening our economy," Mr. Paulson said in prepared remarks for a press conference.
WSJ ($) Read on...

Gold Crashes
Gold futures in New York fell the most in almost 28 years as central banks eased investor concern by pumping cash into global credit markets and U.S. officials said they were developing a plan to stop banks from failing.

Treasury Secretary Henry Paulson and Federal Reserve Chairman Ben S. Bernanke proposed moving troubled assets from the balance sheets of American financial companies into a new institution. U.K. and U.S. regulators cracked down on short sellers, sending stocks in Asia and Europe soaring and reducing the appeal of bullion as an alternative investment. Read on...


Homebuilders Pulte Homes and Toll Brothers buck the trend... both hit new highs despite lethargic construction industry.
Government bailout boosts Big Finance... BB&T, U.S. Bancorp, and Wells Fargo at 52-week highs.

But it doesn't save Big Pharma... Merck and Wyeth at new lows.

Computer giant Dell hits 10-year low.
Last Change 52-Wk
S&P 500

1213.60

+1.75%

-17.81%

Oil (USO)

74.99

-1.72%

+23.60%

Gold (GLD)

76.79

-0.99%

+8.20%

Silver (SLV)

10.40

-5.02%

-18.16%

U.S. Dollar

79.12

+0.19%

-0.73%

Euro
1.42
-0.74%
+2.10%
VIX

30.30

-4.42%

+14.43%

HUI

281.36

+1.61%

-23.00%

10-Year Yield

3.49%

0.01

-0.76

Advertisement

Company Sym Industry

Iowa Telecom

IWA

telecom

Hill-Rom

HRC

medical equip

Ace Limited

ACE

insurance

T. Rowe Price

TROW

asset mgmt

Papa John's

PZZA

restaurant

Heartland Express

HTLD

trucking

BB&T

BBT

bank

Wells Fargo

WFC

bank

National Beverage

FIZZ

beverages

Alcon

ACL

medical equip

PNC Financial

PNC

bank

H&R Block

HRB

taxes

U.S. Bancorp

USB

bank

Nicor

GAS

utilities

Big Lots

BIG

discount retail

Pulte Homes

PHM

homebuilder

Revlon

REV

cosmetics

True Religion

TRLG

designer jeans

Company Sym Industry

Dell

DELL

computers

Merck

MRK

Big Pharma

Gramercy Capital

GKK

commercial REIT

Wyeth

WYE

Big Pharma

Weekend Edition: The Best of The S&A Digest
September 20, 2008

Where to Find the Free Money in Biotech
September 19, 2008

The World's Greatest Market Timer Is Busted
September 18, 2008

Commodity Q&A: Buy Natural Gas Today...
September 17, 2008

We're About to See One Heck of an Explosion in Gold Stocks
September 16, 2008

Home | About GSW | FAQ | GSW Archive | Privacy Policy | Contact Us

Customer Service: 1-888-261-2693 – Copyright 2010 Stansberry & Associates Investment Research. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This e-letter may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Stansberry & Associates Investment Research, LLC. 1217 Saint Paul Street, Baltimore MD 21202